News

Article

Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD

Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.

CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the 2024 American Psychiatric Association (APA) Annual Meeting. In part 1 of their conversation, Miller and Weiden discuss long-acting injectables then and now.

Dr Weiden is a professor at the State University of New York at Stony Brook.

See more coverage from the 2024 APA Annual Meeting in Psychiatric Times at https://www.psychiatrictimes.com/conferences/apa.

Related Videos
Venusvi/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
Kailinin/AdobeStock
Tatiana/AdobeStock
tardive dyskinesia
tardive dyskinesia
tardive dyskinesia
meds pills
covid
© 2025 MJH Life Sciences

All rights reserved.